Acute Myeloid Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
A Study of PRT1419 Injection in Patients With Relapsed/Refractory Hematologic Malignancies
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Orlando, Florida
  • +3 more
2022-03-31
Mar 31, 2022
N
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
  • Acute Myeloid Leukemia
  • +33 more
  • Biospecimen Collection
  • Medical Chart Review
  • Kingman, Arizona
  • +88 more
2022-04-07
Apr 7, 2022
G
Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia
Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
2022-03-31
Mar 31, 2022
S
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Recruiting
  • Acute Myeloid Leukemia
  • +14 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2022-04-07
Apr 7, 2022
O
A Randomized Phase III Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +8 more
2022-03-30
Mar 30, 2022
A
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    2022-04-06
    Apr 6, 2022
    W
    Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
    Recruiting
    • Whole Genome Sequencing
    • +2 more
    • ChromoSeq
    • Saint Louis, Missouri
      Washington University School of Medicine
    2022-04-06
    Apr 6, 2022
    N
    Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Anchorage, Alaska
    • +506 more
    2022-04-05
    Apr 5, 2022
    M
    Psychological Intervention Mobile App for Patients With AML
    Active, not recruiting
    • Acute Myeloid Leukemia
    • Usual Care
    • Psychological intervention
    • Boston, Massachusetts
    • +1 more
    2022-04-05
    Apr 5, 2022
    G
    Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
    Active, not recruiting
    • Acute Myeloid Leukemia
    • La Jolla, California
    • +69 more
    2022-04-05
    Apr 5, 2022
    T
    A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies
    Recruiting
    • Lymphoma
    • +3 more
    • Los Angeles, California
    • +13 more
    2022-03-28
    Mar 28, 2022
    S
    A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies - 2018
    Completed
    • Acute Myeloid Leukemia
    • +8 more
    • DSP-7888 Dosing Emulsion
    • Denver, Colorado
    • +7 more
    2022-04-04
    Apr 4, 2022
    N
    FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
    Active, not recruiting
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +11 more
    2022-04-05
    Apr 5, 2022
    N
    Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy
    Active, not recruiting
    • Acute Myeloid Leukemia
    • Clinical Observation
    • +2 more
    • Birmingham, Alabama
    • +45 more
    2022-04-05
    Apr 5, 2022
    A
    A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
    Active, not recruiting
    • Acute Myeloid Leukemia
    • FLT3-mutated Acute Myeloid Leukemia
    • Anjo, Aichi, Japan
    • +54 more
    2022-04-05
    Apr 5, 2022
    M
    A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
    Active, not recruiting
    • Acute Myeloid Leukemia
    • Standard Leukemia Care
    • Palliative Care
    • Boston, Massachusetts
    • +3 more
    2022-04-05
    Apr 5, 2022
    S
    Alvocidib Biomarker-driven Phase 2 AML Study - 2020
    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Scottsdale, Arizona
    • +37 more
    2022-04-04
    Apr 4, 2022
    I
    Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • S65487 and azacitidine
    • Villejuif, France
    • +7 more
    2022-03-25
    Mar 25, 2022
    J
    CPX-351 Real-World Effectiveness and Safety Study
    Recruiting
    • Acute Myeloid Leukemia
    • Belfast, United Kingdom
    • +14 more
    2022-04-05
    Apr 5, 2022
    N
    Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia
    Suspended
    • Acute Myeloid Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    2022-04-05
    Apr 5, 2022
    S
    Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed AML
    Recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +7 more
    2022-03-27
    Mar 27, 2022
    N
    BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • New Haven, Connecticut
    • +26 more
    2022-04-05
    Apr 5, 2022
    N
    BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Birmingham, Alabama
    • +8 more
    2022-04-05
    Apr 5, 2022
    S
    Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML). - 2020
    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    2022-04-04
    Apr 4, 2022
    S
    Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage
    Recruiting
    • Acute Myeloid Leukemia
    • Orange, California
    • +3 more
    2022-04-05
    Apr 5, 2022